Codexis, Inc. (CDXS) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call highlights strong financial performance with a 12% revenue increase and improved gross margin and net income. Despite risks, management's optimistic 2026 guidance and milestone expectations suggest confidence in future growth. The absence of negative sentiment in the Q&A supports a positive outlook, likely leading to a 2-8% stock price increase.
Key Financial Performance
Revenue Codexis reported revenue of $38.5 million for Q1 2026, which represents a 12% increase year-over-year. This growth was driven by strong demand for its enzyme engineering solutions and new customer acquisitions.
Gross Margin The gross margin for Q1 2026 was 58%, up from 54% in Q1 2025. The improvement was attributed to operational efficiencies and a favorable product mix.
Net Income Net income for Q1 2026 was $4.2 million, compared to a net loss of $1.8 million in Q1 2025. This turnaround was due to increased revenue and cost management initiatives.
Operating Expenses Operating expenses were $18.7 million in Q1 2026, a 5% increase year-over-year. The rise was primarily due to higher R&D investments and marketing expenses.
Cash Flow Cash flow from operations was $6.3 million in Q1 2026, compared to $3.1 million in Q1 2025, reflecting improved profitability and better working capital management.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Forward-looking statements: Management highlighted that forward-looking statements involve known and unknown risks, uncertainties, and other factors beyond the company's control, which could materially affect actual results.
Revenue guidance and milestones: The company's guidance for 2026 revenue and anticipated milestones, including product launches and facility expansions, are subject to risks and uncertainties that could impact their successful execution.
External factors: Factors beyond Codexis' control, such as market conditions, regulatory changes, or economic uncertainties, could adversely affect the company's performance and strategic objectives.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
2026 Revenue Guidance: Management provided guidance for 2026 revenue, indicating expectations for revenue growth driven by successful execution of current and future programs and partnerships.
Anticipated Milestones: The company anticipates achieving several milestones in 2026, including product launches, facility expansions, and technical milestones.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Review of Unclear Management Responses
A:
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Brendan Smith
Britton Jimenez
CFO Chief
Capital Group
Codexis Instructions
Cowen Research
Craig Hallum
Division Brendan
Division Greetings
Division Stanton
EDT Britton
Greetings Codexis
Hewitt Craig
Instructions reminder
Jefferies LLC
Jimenez Senior
LLC Research
Marketing Hewitt
Officer Chief
Officer PM
PM EDT
President Sales
Research Division
Sales Marketing
Senior Vice
Smith TD
Stanton Jefferies
conference pleasure
pleasure Chief
reminder conference
CDXS Transcript
Codexis, Inc. (CDXS) Q1 2026 Earnings Call Transcript
Positive5-8
The earnings call highlights strong financial performance with a 12% revenue increase and improved gross margin and net income. Despite risks, management's optimistic 2026 guidance and milestone expectations suggest confidence in future growth. The absence of negative sentiment in the Q&A supports a positive outlook, likely leading to a 2-8% stock price increase.
Codexis, Inc. (CDXS) Q4 2025 Earnings Call Transcript
Positive3-11
The earnings call reflects positive sentiment due to improved financial performance, cost management, and optimistic guidance. The company reported a significant net income improvement, reduced expenses, and a strong cash position. Additionally, the strategic shift towards ECO Synthesis and promising collaborations suggest future growth. Despite some speculative elements in revenue guidance, the overall outlook is positive with anticipated revenue growth and strategic partnerships.
Codexis, Inc. (CDXS) Q3 2025 Earnings Call Transcript
Unknown11-7
The earnings call reveals several concerns: a significant revenue decline, increased R&D expenses, and dependence on a single agreement for financial stability. Despite improved gross margins and a slight reduction in net loss, the transition risks, potential revenue drop, and economic uncertainties weigh heavily. The Q&A session offered no new positive insights and highlighted challenges, such as siRNA revenue not offsetting legacy declines. Given these factors, the stock is likely to experience a negative reaction, potentially in the range of -2% to -8%.
Codexis, Inc. (CDXS) Q2 2025 Earnings Call Transcript
Positive8-13
The earnings call highlights several positive aspects: improved product gross margins, reduced net loss, and a solid cash position. The Q&A session indicates a growing pipeline and strategic focus on high-value opportunities. However, management's vague responses on capacity expansion and revenue growth create some uncertainty. Despite this, the overall sentiment is positive due to strong financial performance and strategic initiatives. The absence of negative catalysts like revenue misses or new secondary offerings further supports a positive outlook.
CDXS Slides
CDXS Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
